Showing results (111-120 of 230) with videos related to
Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancerUrsula A Matulonis, Neil S Horowitz, Susana M Campos, et al.Gynecologic Oncology Reports|February 22, 2020
Results of an abbreviated phase II study of AKT inhibitor MK-2206 in the treatment of recurrent platinum-resistant high grade serous ovarian, fallopian tube, or primary peritoneal carcinoma (NCT 01283035)Elizabeth K Lee, Zhenying Tan-Wasielewski, Carol Aghajanian, et al.Veterinary Microbiology|December 15, 2010
Q fever in Japan: an update reviewSarah Rebecca Porter, Guy Czaplicki, Jacques Mainil, et al.Journal of Professional Nursing : Official Journal of the American Association of Colleges of Nursing|December 2, 2023
Academic-Practice Partnership to Strengthen Nursing Care of Older AdultsJill Brennan-Cook, Rebecca Porter, Sarah Tucker, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancerMichael J Callahan, Zoltan Nagymanyoki, Tomas Bonome, et al.Gynecologic Oncology|September 19, 2003
Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumorsSusanna M Campos, Ursula A Matulonis, Richard T Penson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2018
Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab SoravtansineUrsula A Matulonis, Michael J Birrer, David M O'Malley, et al.Gynecologic Oncology|July 10, 2021
Sequential Phase II clinical trials evaluating CRLX101 as monotherapy and in combination with bevacizumab in recurrent ovarian cancerCarolyn N Krasner, Susana M Campos, Chantay L Young, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2021
Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous CarcinomaJoyce F Liu, Niya Xiong, Susana M Campos, et al.Cancer Research Communications|February 11, 2025
Functional Profiling of p53 and RB Cell Cycle Regulatory Proficiency Suggests Mechanism-Driven Molecular Stratification in Endometrial CarcinomaZelei Yang, Saie Mogre, Hyeji Jun, et al.Pageof 23